“Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan” (2024) Dermatology Practical & Conceptual, 14(3), p. e2024186. doi:10.5826/dpc.1403a186.